Endothelial cell calcium channel

The term "Endothelial cell calcium channel" is not the canonical name for a single, well-defined molecular target. Instead, it refers broadly to several types of ion channels and transporters in endothelial cells that mediate the movement of calcium ions (Ca²⁺) across cellular membranes. These include voltage-gated Ca²⁺ channels (Cav), store-operated Ca²⁺ entry channels such as Orai/STIM complexes, transient receptor potential (TRP) channels, and intracellular receptors like the inositol trisphosphate receptor involved in releasing Ca²⁺ from internal stores[2][4]. Calcium signaling in endothelial cells is essential for numerous physiological processes including regulation of vascular tone and permeability, control of coagulation states, angiogenesis, immune responses such as leukocyte transmigration during inflammation, and maintenance of barriers like the blood-brain barrier[1][2][3][4]. Disruption or dysregulation of these pathways contributes to cardiovascular diseases and inflammatory conditions. Because "Endothelial cell calcium channel" does not specify a unique protein or gene product but rather describes a functional group within the endothelium's complex signaling machinery,[6] it is not considered an actionable therapeutic target by itself. Instead, research focuses on individual components—such as Cav subunits or TRP family members—that can be specifically targeted by drugs. In summary: This entry is too broad/vague to serve as a canonical therapeutic target; more precise identification—such as specifying "Voltage-dependent L-type calcium channel subunit alpha1C" or "Orai1 store-operated calcium entry channel"—would be required for structured drug discovery purposes.[6]

Other names

Endothelial calcium channelEndothelial Ca2+ channelVascular endothelial calcium channel (rarely used)

No direct mechanism; various agents can affect endothelial Ca²⁺ influx or release from stores via different pathways such as store-operated channels or G protein-coupled receptor activation.